Treatment of Newly-Diagnosed AML with Idarubicin + ARA-C

E. Estey; H. Kantarjian; S. O'BRIEN; E. Feldman; C. Roller; M. Beran; M. Andreeff; S. Escudier; S. Kornblau; M. Keating

doi:10.3109/10428199209058686

Treatment of Newly-Diagnosed AML with Idarubicin + ARA-C

E. Estey
, H. Kantarjian
, S. O'BRIEN
, E. Feldman
, C. Roller
, M. Beran
, M. Andreeff
, S. Escudier
, S. Kornblau
, M. Keating

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	121
Number of pages	1
Journal	Leukemia and Lymphoma
Volume	7
Issue number	sup2
DOIs	https://doi.org/10.3109/10428199209058686
State	Published - Jan 1 1992
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428199209058686

Cite this

@article{9148c06c6a4148d582e907671e046e98,

title = "Treatment of Newly-Diagnosed AML with Idarubicin + ARA-C",

author = "E. Estey and H. Kantarjian and S. O'BRIEN and E. Feldman and C. Roller and M. Beran and M. Andreeff and S. Escudier and S. Kornblau and M. Keating",

year = "1992",

month = jan,

day = "1",

doi = "10.3109/10428199209058686",

language = "English (US)",

volume = "7",

pages = "121",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "sup2",

}

TY - JOUR

T1 - Treatment of Newly-Diagnosed AML with Idarubicin + ARA-C

AU - Estey, E.

AU - Kantarjian, H.

AU - O'BRIEN, S.

AU - Feldman, E.

AU - Roller, C.

AU - Beran, M.

AU - Andreeff, M.

AU - Escudier, S.

AU - Kornblau, S.

AU - Keating, M.

PY - 1992/1/1

Y1 - 1992/1/1

UR - https://www.scopus.com/pages/publications/84961433527

UR - https://www.scopus.com/pages/publications/84961433527#tab=citedBy

U2 - 10.3109/10428199209058686

DO - 10.3109/10428199209058686

M3 - Comment/debate

AN - SCOPUS:84961433527

SN - 1042-8194

VL - 7

SP - 121

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - sup2

ER -

Treatment of Newly-Diagnosed AML with Idarubicin + ARA-C

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this